ON

Onebiosciences

1 known investors

onebiosciences.fr ↗

One Biosciences offers a single-cell analysis platform that resolves tumor samples (FFPE or frozen) cell by cell, producing single-cell maps and clinician-ready reports within two weeks. The AI-supported platform is validated across multiple tumor types and aimed at bringing single-cell data into clinical use.

Investors · 1

PO

Polytechnique VenturesParis